Forge Therapeutics and Evotec present efficacy data for LpxC Inhibitor in urinary tract, lung, thigh, and abdominal infection models at ASM ESCMID 2017

San Diego, California, September 7, 2017 – Forge Therapeutics, Inc., [...]

2017-09-07T21:37:57-07:0009.07.2017|Press Releases|

Forge Therapeutics and Evotec to present preclinical data on novel antibiotic program at 2017 ASM/ESCMID Conference

San Diego, California, August 29, 2017 – Forge Therapeutics, Inc., [...]

2017-08-29T21:42:17-07:0008.29.2017|Press Releases|
Go to Top